Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$452M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$359M |
| 3 |
Accenture
ACN
|
+$329M |
| 4 |
Becton Dickinson
BDX
|
+$318M |
| 5 |
Coca-Cola
KO
|
+$269M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$517M |
| 2 |
Chevron
CVX
|
+$454M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$355M |
| 5 |
Dollar Tree
DLTR
|
+$348M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.79% |
| 2 | Financials | 11.74% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
| $42.9M | 0.01% |
282,135
+122,748
| +77% | +$18.2M |
|
877
Merit Medical Systems
MMSI
$5.36B
| $42.9M | 0.01% |
663,478
+57,303
| +9% | +$3.54M |
|
|
AAT
878
American Assets Trust
AAT
$1.38B
| $42.9M | 0.01% |
1,149,917
-3,525
| -0.3% | -$126K |
|
879
Macy's
M
$6.55B
| $42.9M | 0.01% |
2,261,648
+173,542
| +8% | +$3.08M |
|
880
iShares Global Tech ETF
IXN
$9.17B
| $42.6M | 0.01% |
755,334
-129,498
| -15% | -$6.97M |
|
881
Moody's
MCO
$82.8B
| $42.4M | 0.01% |
117,055
-10,945
| -9% | -$3.64M |
|
882
Bruker
BRKR
$8.58B
| $42.3M | 0.01% |
556,880
-648,356
| -54% | -$45.3M |
|
883
Carriage Services
CSV
$544M
| $41.9M | 0.01% |
1,133,521
-3,762
| -0.3% | -$140K |
|
884
TAL Education Group
TAL
$6.93B
| $41.8M | 0.01% |
1,657,577
+262,937
| +19% | +$11.7M |
|
885
Vanguard ESG US Stock ETF
ESGV
$13.6B
| $41.6M | 0.01% |
519,784
+35,762
| +7% | +$2.77M |
|
886
Range Resources
RRC
$9.41B
| $41.6M | 0.01% |
2,479,147
-167,233
| -6% | -$2.1M |
|
887
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.7B
| $41.4M | 0.01% |
175,046
+8,918
| +5% | +$2M |
|
888
Arrowhead Research
ARWR
$12.5B
| $41.3M | 0.01% |
498,163
+4,857
| +1% | +$362K |
|
889
W.P. Carey
WPC
$16.1B
| $41.1M | 0.01% |
567,702
+28,210
| +5% | +$2.06M |
|
890
Curtiss-Wright
CW
$25.6B
| $41M | 0.01% |
344,995
-67,151
| -16% | -$8.4M |
|
891
BioLife Solutions
BLFS
$1.69B
| $40.9M | 0.01% |
919,001
+1,220
| +0.1% | +$43K |
|
892
Sunrun
RUN
$2.38B
| $40.8M | 0.01% |
732,077
-2,970
| -0.4% | -$143K |
|
893
Resideo Technologies
REZI
$3.67B
| $40.7M | 0.01% |
1,356,223
-201,320
| -13% | -$5.96M |
|
894
Dynatrace
DT
$14.6B
| $40.6M | 0.01% |
694,398
+19,812
| +3% | +$1.03M |
|
895
Vanguard Consumer Staples ETF
VDC
$7.94B
| $40.6M | 0.01% |
222,246
+31,701
| +17% | +$5.79M |
|
896
Diamondback Energy
FANG
$55.7B
| $40.5M | 0.01% |
423,769
-81,628
| -16% | -$6.73M |
|
897
First Hawaiian
FHB
$3.32B
| $40.5M | 0.01% |
1,428,225
-324,847
| -19% | -$9.1M |
|
898
Helmerich & Payne
HP
$4.18B
| $40.3M | 0.01% |
1,235,937
+77,732
| +7% | +$2.29M |
|
899
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $40.2M | 0.01% |
883,636
-732,874
| -45% | -$32.8M |
|
900
GSK
GSK
$104B
| $40.1M | 0.01% |
803,764
-562,670
| -41% | -$27M |
|
Similar funds
Ameriprise's Q2 2021 Portfolio in Review
As of Q2 2021, Ameriprise held 4,059 positions worth $323B, up 7.5% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q2 2021 filing shows 217 new, 1,726 increased, 1,816 reduced and 179 closed positions. Its largest new stake was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M. The largest sale was UnitedHealth, an estimated $517M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2021 buy was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M.
- Ameriprise added most to ExxonMobil in Q2 2021, an estimated $452M increase.
- Ameriprise's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $517M.
- Ameriprise fully exited INPHI CORPORATION in Q2 2021, selling an estimated $139M.
- Ameriprise's ten largest holdings make up 15% of its $323B portfolio in Q2 2021.
- Ameriprise opened 217 new positions and closed 179 in Q2 2021.
- Ameriprise's portfolio value rose 7.5% quarter-over-quarter to $323B.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.